Feature|Videos|October 21, 2025

Understanding FDA Authorization—and How The Joint Commission Can Help Enforce UV Technology

The moderator was stunned by the sheer number of UV “robots” on display at conferences—and left with a simple question: How can hospitals tell which devices are truly authorized and which are not? That confusion is exactly why we convened this roundtable: to clarify the FDA pathway, help vendors and buyers understand that authorization is essential, and guide health systems toward compliant, defensible choices. With that in mind, our next topic is enforcement: What is the FDA actually doing now, and what should happen to curb the marketing and sale of unregulated devices?

Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.